[Immune checkpoint inhibition in Merkel cell carcinoma].

Terheyden, P; Mohr, A; Langan, E A

[Immune checkpoint inhibition in Merkel cell carcinoma]. / Immuncheckpointinhibition beim Merkel-Zell-Karzinom.

Terheyden, P; Mohr, A; Langan, E A.

Affiliation

Terheyden P; Klinik für Dermatologie, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland. Patrick.Terheyden@uksh.de.
Mohr A; Klinik für Dermatologie, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.
Langan EA; Klinik für Dermatologie, Universität zu Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.

Hautarzt ; 70(9): 684-690, 2019 Sep.

Article in De | MEDLINE | ID: mdl-31468071

Subject(s)

Antibodies, Monoclonal/administration & dosage; Carcinoma, Merkel Cell/drug therapy; Carcinoma, Merkel Cell/immunology; Skin Neoplasms/drug therapy; Skin Neoplasms/immunology; Antibodies, Monoclonal/adverse effects; Antineoplastic Agents/administration & dosage; Antineoplastic Agents/adverse effects; B7-H1 Antigen/antagonists & inhibitors; Carcinoma, Merkel Cell/pathology; Humans; Neoplasm Recurrence, Local; Skin Neoplasms/pathology; Treatment Outcome; Ultraviolet Rays

Key words

Chemotherapy; Immunotherapy; Merkel cell polyomavirus; Metastases; Polyomavirus

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Merkel Cell / Antibodies, Monoclonal Type of study: Risk_factors_studies Limits: Humans Language: De Journal: Hautarzt Year: 2019 Document type: Article

Fulltext

XML

PubMed Links

Search on Google